When was MedGenome founded?

MedGenome was founded in 2013 and raised its 1st funding round within a year of its incorporation.

Where is MedGenome located?

MedGenome is headquartered in Bengaluru, India. It is registered at Sy. Nos. 94/1C and 94/2, Tower 1, Ground Floor, Veerasandra Village, Attibele Hobli, Electronic City Phase-1, Electronics City, Bangalore, Bangalore South, Karnataka, India, 560100.

Who is the current CEO of MedGenome?

Mahesh Pratapneni, Mahesh Pratapneni and Vedam Ramprasad s of MedGenome. Mahesh Pratapneni has also founded 2 companies and is angel investors in 3 startups.

Which legal entities is MedGenome associated with?

MedGenome is associated with MEDGENOME INC and 1 other.

How many employees does MedGenome have?

As of May 31, 2025, MedGenome has 922 employees, reflecting a 5% year-over-year growth in headcount.

Is MedGenome a funded company?

MedGenome is a funded company, having raised a total of $264M across 10 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Aug 20, 2013.

How much is MedGenome worth?

The latest valuation of MedGenome is ₹***** as of Dec 18, 2021.

When was the latest funding round of MedGenome?

MedGenome's latest funding was a $***** Series E round on Jul 21, 2025, with participation from 3 investors. Its primary sector is Clinical Laboratory Chains. In India, the Clinical Laboratory Chains sector has seen $35.7M in funding in 2026 to date.

What is the annual revenue of MedGenome?

Annual revenue of MedGenome is between ₹100 Cr and ₹500 Cr as on Mar 31, 2025

Where does MedGenome rank among its competitors?

MedGenome ranks 2nd amongst 71 active competitors, of which 10 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Orange Health, which secured $30M in May, 2026.

Who are the top competitors of MedGenome?

MedGenome's top competitors include Dr Lal PathLabs, Orange Health and Metropolis India. Among them, Orange Health secured the most recent funding round in May, 2026.

MedGenome - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Provider of DNA sequencing, bioinformatics, and multiomics services. It offers a comprehensive suite of genomic services which include whole genome and exome sequencing, single-cell sequencing, spatial transcriptomics, and immune profiling. It also provides robust bioinformatics support, including analysis pipelines and data visualization tools, to facilitate research and drug discovery. The services are tailored to support research in various areas, including rare disease research, cancer research, and antibody discovery.

Website: medgenome.com
Social
Part Of
Registered Address: Sy. Nos. 94/1C and 94/2, Tower 1, Ground Floor, Veerasandra Village, Attibele Hobli, Electronic City Phase-1, Electronics City, Bangalore, Bangalore South, Karnataka, India, 560100

Key Metrics

Founded Year

2013

Location

Bengaluru, India

Stage

Series E

Total Funding

$264M in 10 rounds

Latest Funding Round

Series E, Jul 21, 2025, $*****

Post Money Valuation

₹***** as on Dec 18, 2021

Investors

Peak XV Partners & 31 more

Ranked

2^nd among 71 active competitors

Annual Revenue

₹100 - ₹500 Cr as on Mar 31, 2025

Employee Count

922 as on May 31, 2025

Investment & Acquisitions

SDRC & 5 more

Similar Companies

Caris Life Sciences & 335 more

View MedGenome's full profile

MedGenome is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MEDGENOME LABS LIMITED CIN: U73100KA2013PLC084414 , India, Active	Apr 08, 2013	₹100 - ₹500 Cr (As on Mar 31, 2025)	1021 (As on Apr 01, 2026)
MEDGENOME INC CIN: 32076340333 , United States, Active		-	-	-

MedGenome has raised a total funding of $264M over 10 rounds. Its first funding round was on Aug 20, 2013. Its latest funding round was a Series E round on Jul 21, 2025 for $*****. 3 investors participated in its latest round. MedGenome has 21 institutional investors and 11 angel investors.

Here is the list of recent funding rounds of MedGenome:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 21, 2025	3524597	Series E	5170104	1948413	9469330	2266462
Aug 30, 2022	1812930	Series D	8573104	8939979	8729164	Sofina & 1 more
Jul 15, 2021	8503620	Series D	8572571	3823817	Kemwel	IFC

Access funding benchmarks and valuations. Sign up today!

View details of MedGenome's funding rounds and investors

The founders of MedGenome are Mahesh Pratapneni, Sreedhar Santhosh, Sam Santhosh and Mahesh Pratapneni. Mahesh Pratapneni, Mahesh Pratapneni, Felix Olale and Vedam Ramprasad are the CEOs of MedGenome.

Here are the details of MedGenome's key team members:

Mahesh Pratapneni: Co-Founder & Group CEO of MedGenome and founder of 2 other companies, Emerge Ventures and GenomeAsia 100K. They are also an angel investor in 3 startups and serve on the boards of 4 companies.
Contact Info: 1 phone number
Sreedhar Santhosh: Co-Founder of MedGenome and founder of 1 other company. They are also an angel investor in 1 startup and serve on the board of 1 company.
Sam Santhosh: Former Co-Founder & Chairman of MedGenome and founder of 4 other companies, including SciGenom, AgriGenome Labs and SciGenom Research Foundation. They serve on the board of 1 company.
Contact Info: 2 phone numbers
Mahesh Pratapneni: Co-Founder and Group CEO of MedGenome and founder of 2 other companies, Emerge Ventures and Genomeasia100K.
Contact Info: 1 email address and 1 phone number
Vedam Ramprasad: CEO of MedGenome.
Contact Info: 1 email address

MedGenome's Board of Directors

MedGenome's board has 4 active members. Mahesh Pratapneni is part of team and Prasad Bhagwan Shejale, Navjeewan Jatinder Khosla and Shankar Mahadevappa Prasad are independent board members.

Here is the list of MedGenome's board of directors:

Name	Type	Representing	Status	Duration
Mahesh Pratapneni	Team	-	Current	6y 9m
Prasad Bhagwan Shejale	Independent board member	-	Current	6y 9m
zsidzif	Independent board member	-	Current	7y 1m
o{sokyp	Independent board member	-	Current	2y 2m

View details of MedGenome's Founder profiles and Board Members

MedGenome's employee count trend

MedGenome has 922 employees as of May 25. The total employee count is 5.0% more than what it was in May 24. Here is MedGenome's employee count trend over the years:

Uncover MedGenome's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MedGenome include Dr Lal PathLabs, Orange Health and Metropolis India. Here is the list of Top 10 competitors of MedGenome, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Dr Lal PathLabs 1949, Gurugram (India), Public	Chain of pathology and radiology labs	$13.9M	WestBridge Capital, Jashvik Capital & 3 others	78/100
2nd	MedGenome 2013, Bengaluru (India), Series E	Provider of DNA sequencing, bioinformatics, and multiomics services	$264M	HDFC Life, HDFC Mutual Fund & 30 others	71/100
3rd	Orange Health 2020, Bengaluru (India), Series C	Chains providing at-home diagnostic testing and health checkup services	$77.1M	General Catalyst, Bertelsmann India Investments ... & 15 others	69/100
4th	Metropolis India 1981, Mumbai (India), Public	Chain of diagnostic centers	$232M	The Carlyle Group, Warburg Pincus & 13 others	68/100
5th	CORE 2012, Gurugram (India), Acquired	Laboratory offering biomarker analysis	$17.3M	Artiman, Eight Roads Ventures & 2 others	53/100
6th	Lilac Insights 2011, Mumbai (India), Series A	Provider of genetic diagnostic advisory services for infant	$11M	Tara Fund, Ranay Shah Family Trust & 53 others	52/100
7th	Sterling Accuris Diagnostics 2015, Ahmedabad (India), Series C	Chain of pathology labs	$41.7M	Udhay Vi Realty, Morgan Stanley & 11 others	51/100
8th	Airmed 2016, Ahmedabad (India), Seed	Provider of a chain of diagnostic labs	$1.54M	Brand Capital	49/100
9th	CRL Diagnostics 2015, Delhi (India), Unfunded	Chain of pathology laboratory services	-	-	49/100
10th	OncoStem 2011, Bengaluru (India), Series A	Developer of prognostic tests for the detection of cancer	$9M	Artiman, Peak XV Partners & 1 others	45/100